Version 2.78

Term Description

This term should be used for assays that detect the presence of antibodies to HIV-1 and/or -2 but do not differentiate between the two. This term was created for, but is not limited in use to, the bioMerieux VIKIA HIV 1/2 assay for the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma, or whole blood. The VIKIA HIV 1/2 assay result should be read 30 minutes after the sample is applied to the sample well.
Source: Regenstrief LOINC

Part Description

LP16715-2   HIV 1+2
Two types of human immunodeficiency viruses (HIV) have been characterized: HIV-1 and HIV-2. HIV-1 was initially discovered in the early 1980s and thought to be the sole causative agent of HIV infections and ultimately AIDS. In 1986, HIV-2 was isolated and also found to cause AIDs. HIV-1 is more virulent and the predominant cause of the HIV infections worldwide. HIV-2 is poorly transmitted and is primarily concentrated in West Africa.

Presently (2012), HIV-1 strains are divided into four groups, including group M (major) with subtypes A through K, group O (outlier), group N (non-M or O), and group P. HIV-2 is divided into subtypes A through E. Occasionally, two viruses of different subtypes can "cross react" and blend their genetic material to create a new hybrid HIV virus. However, many of these new strains do not survive for long. Studies have also shown that the core proteins of HIV-1 and HIV-2 display frequent cross-reactivity whereas the envelope proteins are more type-specific. Source: Regenstrief LOINC

Fully-Specified Name

Component
HIV 1+2 Ab
Property
PrThr
Time
Pt
System
Ser/Plas/Bld
Scale
Ord
Method
IA.rapid

Additional Names

Short Name
HIV1+2 Ab SerPlBld Ql IA.rapid
Display Name
HIV 1+2 Ab IA.rapid Ql (S/P/Bld)
Consumer Name Alpha Get Info
HIV 1+2 antibody, Blood

Example Answer List: LL744-4

Source: Regenstrief Institute
Answer Code Score Answer ID
Detected LA11882-0
Not detected LA11883-8

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.54
Last Updated
Version 2.56
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) VIH 1-2 Anticuerpos:PrThr:Punto temporal:Suero, Plasma o Sangre:Ord:IA.rapid
es-MX Spanish (Mexico) VIH 1 + 2 Ab:Presencia o umbral:Punto temporal:Suero, plasma o sangre:Ordinal:Inmunoensayo rápido
et-EE Estonian (Estonia) HIV 1+2 antikehad:PrThr:Pt:S/P/B:Ord:IA.rapid
Synonyms: Inimese immuunpuudulikkuse viirus Inimese immuunpuudulikkuse viiruse 1. ja 2 tüüp Järgarvuline Juhuslik Plasma Seerum Seerum või plasma Seerum või plasma või veri Veri
fr-CA French (Canada) VIH 1+2, Ac:Présence-Seuil:Temps ponctuel:Sérum/Plasma/Sang:Ordinal:IA.rapide
fr-FR French (France) VIH-1+2 Ac:Présence/Seuil:Ponctuel:Sérum/Plasma/Sang:Qualitatif:Immunoanalyse rapide
fr-BE French (Belgium) VIH 1+2 Ac:PrThr:Temps ponctuel:Sérum/Plasma/Sang:Ordinal:IA.rapid
Synonyms: Anticorps HIV HIV 1 HIV 1&2 HIV 1+2
it-IT Italian (Italy) HIV 1+2 Ab:PrThr:Pt:Siero/Plasma/Sangue:Ord:IA.rapido
Synonyms: anticorpo Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue Siero Siero o Plasma Siero,Plasma o Sangue
nl-NL Dutch (Netherlands) HIV 1+2 As:aanwezigheid:moment:serum of plasma of bloed:ordinaal:immunoassay.sneltest
Synonyms: antistof; antilichaam IA IA.rapid
pl-PL Polish (Poland) HIV 1+2 Ab:granica wykrywalności:punkt w czasie:surowica, osocze lub krew:półilościowy:szybka metoda immunologiczna
Synonyms: Ludzki wirus niedoboru odporności typu 1 Ludzki wirus niedoboru odporności typu 1 i 2 Ludzki wirus niedoboru odporności typu 1+2 Przeciwciała do HIV 1 i 2 Przeciwciała do HIV 1+2
ru-RU Russian (Russian Federation) HIV 1+2 Ат:PrThr:ТчкВрм:Сыв/Плаз/Кр:Пор:IA.rapid
Synonyms: Антитело ВИЧ ВИЧ 1 ВИЧ 1 и 2 ВИЧ 1+2 Кровь Плазма Порядковый Сыворотка Сыворотка или Плазма Сыворотка, Плазма или Кровь Точка во времени;Момент
tr-TR Turkish (Turkey) HIV 1+2 Ab:MevcEşik:Zmlı:Ser/Plaz/Kan:Srl:İA.hızlı
Synonyms: Ak İmmünölçüm, immünoassay Mevcut
zh-CN Chinese (China) HIV 1 型+2 型 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫测定法.快速
Synonyms: Ⅰ Ⅱ Ab;自身抗体 AIDS;AIDS 病毒;人类免疫缺陷病毒;人类免疫缺陷病毒（Human immunodeficiency virus，HIV）;爱滋病;艾滋病;艾滋病病毒;获得性免疫缺陷综合征;获得性免疫缺陷综合征（Acquired Immure Deficiency Syndrome，AIDS，艾滋病） HIV 1 & 2 Ab HIV 1+2 Ab HIV1;HTLV 3;HTLV III;人类免疫缺陷病毒 1 型;人类免疫缺陷病毒 I 型;HIV 1 型（人类免疫缺陷病毒 1 型、人类免疫缺陷病毒 I 型、人免疫缺陷病毒 1 型、人免疫缺陷病毒 I 型、HIV I、HIV I 型、艾滋病病毒 I 型） I II 人类免疫缺陷病毒 1 & 2 型 Ab 人类免疫缺陷病毒 1 & 2 型抗体 人类免疫缺陷病毒 1 与 2 型 Ab 人类免疫缺陷病毒 1 与 2 型;HIV（人类免疫缺陷病毒、人免疫缺陷病毒、艾滋病病毒） 1 型（I 型） 与 2 型（II 型） 人类免疫缺陷病毒 1 与 2 型抗体 人类免疫缺陷病毒 1+2 型 Ab 人类免疫缺陷病毒 1+2 型;HIV 1+2 型（人类免疫缺陷病毒 1+2 型、人类免疫缺陷病毒 I+II 型、人免疫缺陷病毒 1+2 型、人免疫缺陷病毒 I+II 型、HIV I+II、HIV I+II 型、艾滋病病毒 I+II 型） 人类免疫缺陷病毒 1+2 型抗体 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 快速免疫测定;快速免疫测定法;快速免疫分析法;快速免疫检定法;快速免疫检定;快速免疫试验;酶免疫测定法.快速;快速酶免疫测定法;快速酶免疫测定;快速酶免疫分析法;快速酶免疫检定法;快速酶免疫检定;快速酶免疫试验 时刻;随机;随意;瞬间 血;血液 血浆或全血;血浆/血液;血浆或血液 血清、血浆或全血;血清、血浆或血液;血清/血浆/血液 血清或血浆

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=80387-4